Scientific EXPERT Act of 2025
H.R. 1532
This bill requires the Food and Drug Administration (FDA) to facilitate and participate in externally led, science-focused drug development meetings to discuss the development of treatments for rare diseases and conditions.
Read the full summary in the Pocket Congress app.